ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
failure to respond or late response
on 10 Oct 2024
Last Applicant/ Owned by
NL-1098 XH Amsterdam
NL
Serial Number
79379532 filed on 25th Aug 2023
Registration Number
N/A
Correspondent Address
NL-5611 CA Eindhoven,
NETHERLANDS
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
SORTAG
Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; research and product development in the field of pharmaceutics Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases Read More
Classification Information
Class [044]
Medical, Beauty & Agricultural Services
Gene and nucleic acid delivery, gene and nucleic acid transfer, gene and nucleic acid regulation and gene and nucleic acid modulation for the treatment of metabolic disorders, ocular disorders, diseases of the nervous system, blood disorders, liver disorders, muscular disorders, muscular skeletal disorders, cancers, infectious diseases, inflammatory and auto-immune diseases, vascular disorders, inherited disorders, genetic disorders and single gene disorders; consultancy in the field of pharmaceutics
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Research, product development and consultancy in the field of biotechnology, biologics, medical science, chemistry and biochemistry; research and product development in the field of pharmaceutics
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Viral systems, gene therapy systems, nucleic acid delivery systems, namely, viral vectors, non-viral vectors, gene therapy vectors, nucleic acid delivery vectors, and cells transformed by viral vectors, non-viral vectors, gene therapy vectors or nucleic acid delivery vectors for medical purposes; pharmaceutical products; biological preparations for use in medical and clinical gene therapy, nucleic acid-based therapy and cell therapy; clinical medical reagents for use in nucleic acid-based therapy, gene therapy, cell therapy, gene diagnosis and gene testing; pharmaceutical preparations, vaccines, prophylaxis products and other pharmaceutical products for use in nucleic acid-based therapy, gene therapy and cell therapy
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79379532
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 10th Oct 2024 | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND |
| 10th Oct 2024 | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE |
| 24th Apr 2024 | REFUSAL PROCESSED BY IB |
| 29th Mar 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 28th Mar 2024 | REFUSAL PROCESSED BY MPU |
| 10th Mar 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 09th Mar 2024 | NON-FINAL ACTION WRITTEN |
| 06th Mar 2024 | ASSIGNED TO EXAMINER |
| 03rd Oct 2023 | APPLICATION FILING RECEIPT MAILED |
| 29th Sep 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |